Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
RegulatoryWatchMinormateriality 56 out of 100
What happened
FactPendency of Litigation(s)/dispute(s) or the outcome impacting the Company. Generics Limited (“JGL”) (a wholly owned step down Indian subsidiary) has.
Why it matters
CapitSignal interpretationLitigation creates a contingent liability that is not in reported profit until it crystallises.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Guidance
WithdrawnEarlierFY27
Revenue: ~ 3x of FY24
NowFY27
Expect technology transfer revenues to start in Q4’FY27
Change
FactGuidance withdrawn
Implication
CapitSignal interpretationThe stated timeline moved by -12 quarter(s) (FY30 to Q4 FY27).confidence 60%
Watch next
Fact- Amount claimed against the company
- Whether a provision has been made
- Next hearing or order date
- EBITDA Margin: More than 25% (management committed by FY30)
- Revenue: ~ 3x of FY24 (management committed by FY30)
Evidence
- Jubilant Pharmova Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company(opens the original filing in a new tab)
- Earlier statement · FY27
- Latest statement · FY27
- Earlier statement · FY27
How CapitSignal classified this
- Reasoning:
- LITIGATION base 56; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%